303 related articles for article (PubMed ID: 22960434)
1. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
[TBL] [Abstract][Full Text] [Related]
2. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
Roth T; Rippon GA; Arora S
Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
[TBL] [Abstract][Full Text] [Related]
3. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H
Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692
[TBL] [Abstract][Full Text] [Related]
4. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
[TBL] [Abstract][Full Text] [Related]
5. Effects of donepezil on memory and cognition in multiple sclerosis.
Christodoulou C; Melville P; Scherl WF; Macallister WS; Elkins LE; Krupp LB
J Neurol Sci; 2006 Jun; 245(1-2):127-36. PubMed ID: 16626752
[TBL] [Abstract][Full Text] [Related]
6. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of modafinil in patients with multiple sclerosis: A clinical trial.
Ford-Johnson L; DeLuca J; Zhang J; Elovic E; Lengenfelder J; Chiaravalloti ND
Rehabil Psychol; 2016 Feb; 61(1):82-91. PubMed ID: 26654280
[TBL] [Abstract][Full Text] [Related]
8. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
Hester R; Lee N; Pennay A; Nielsen S; Ferris J
Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
[TBL] [Abstract][Full Text] [Related]
9. The effects of armodafinil on objective sleepiness and performance in a shift work disorder sample unselected for objective sleepiness.
Howard R; Roth T; Drake CL
J Clin Psychopharmacol; 2014 Jun; 34(3):369-73. PubMed ID: 24717254
[TBL] [Abstract][Full Text] [Related]
10. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
12. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
14. Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia.
Krystal AD; Preud'homme XA
Sleep; 2017 Jan; 40(1):. PubMed ID: 28364461
[TBL] [Abstract][Full Text] [Related]
15. Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial.
Joos L; Goudriaan AE; Schmaal L; van den Brink W; Sabbe BG; Dom G
J Psychopharmacol; 2013 Nov; 27(11):998-1006. PubMed ID: 24045883
[TBL] [Abstract][Full Text] [Related]
16. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
[TBL] [Abstract][Full Text] [Related]
18. American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study.
Kim E; Cameron M; Lovera J; Schaben L; Bourdette D; Whitham R
Mult Scler; 2011 Dec; 17(12):1523-6. PubMed ID: 21803872
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
